Mounjaro®
Starting from £179.99/mo
Start journey Learn morePost-meal sleepiness on Mounjaro is one of those things that catches people off guard. Tirzepatide slows gastric emptying significantly, which means your body spends longer processing a meal — and that sustained digestive effort, combined with the medicine's effect on appetite-regulating hormones, often brings a wave of fatigue once you've eaten. It isn't dangerous, but it is worth understanding. As a prescription-only medicine, Mounjaro is assessed and dispensed by a clinician who can help you work out whether what you're feeling is expected or worth a closer look.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You sat down for lunch, managed about half of what you'd normally eat, and twenty minutes later you felt like you needed a nap. If that sounds familiar, you're not imagining it. Tirzepatide (the active medicine in Mounjaro) activates two gut-hormone receptors, GIP and GLP-1, both of which are involved in how your body processes food. One of their combined effects is a marked slowing of gastric emptying: food moves through the stomach more slowly than it would without the medicine. That sustained digestive work keeps blood flowing toward the gut, diverts energy, and often brings a tiredness that settles in during or just after eating.
There's also a hormonal dimension. GLP-1 and GIP influence signalling pathways that affect alertness and satiety. When both are activated simultaneously (as they are with tirzepatide) the fullness signals that reach the brain are stronger and longer-lasting than most people are used to. The result, for many, is that post-meal heaviness that used to take a large Sunday roast to produce, now arriving after a modest plate of food.
The NHS patient information page for tirzepatide lists fatigue and dizziness among the recognised side effects of Mounjaro, alongside the more commonly discussed gastrointestinal symptoms. Post-meal sleepiness sits within that broader fatigue picture, it's not unusual, and for most people it settles.
The sleepiness after eating tends to peak early in treatment, particularly in the first two to four weeks, and again after each dose increase. Those are the moments when your digestive system is adjusting to a new level of gastric-emptying slowdown. Many people find that once their body has had time to adapt (usually within a couple of weeks of a stable dose) the post-meal drowsiness becomes much less pronounced.
What you eat also matters more than people expect. A large, high-fat or high-carbohydrate meal asks more of the digestive process under any circumstances; on Mounjaro, that meal sits in the stomach for longer than it normally would, stretching out the body's response. Smaller, protein-forward meals with plenty of vegetables tend to produce a gentler digestive load. If you're unsure how to structure eating around your treatment, the guidance on what to eat on Mounjaro covers this in practical terms.
Timing your injection can occasionally play a role too, and if you're wondering whether it matters if you take Mounjaro after eating, that page explains how food timing around your injection can affect tolerance. Worth mentioning to your prescriber if the pattern is disruptive.
One misconception worth letting go gently: many people assume the tiredness means the medicine isn't agreeing with them, or that they've done something wrong. It usually doesn't mean either. It's the medicine working as intended (slowing digestion, reducing appetite, modulating gut hormones) and the body registering that shift.
Post-meal fatigue that eases after thirty minutes or so is generally within the expected range. A few things put it in different territory. If the tiredness is severe, doesn't lift, or is accompanied by dizziness when you stand up, dehydration may be a factor, particularly if nausea, vomiting or diarrhoea have been reducing your fluid intake. Mounjaro can reduce how much you drink as well as how much you eat, and dehydration can compound fatigue significantly.
Severe, persistent abdominal pain that extends toward the back, especially alongside vomiting, is a different matter entirely. That pattern can signal pancreatitis, which the MHRA has flagged as an infrequent but serious risk with GLP-1 medicines. The MHRA Yellow Card scheme exists for reporting suspected side effects, and your prescriber should hear about anything that concerns you between doses.
If you're also experiencing stomach pain after eating alongside the tiredness, there's more detail on that at what causes stomach pain after eating on Mounjaro. And if you're finding your appetite comes back faster than expected between doses, the page on feeling hungry again after three days addresses why that happens and what to do about it.
For a broader picture of how Mounjaro works as a treatment, our Mounjaro overview covers the mechanism, the clinical evidence and what the private treatment pathway looks like. If you're at the stage of weighing up the cost of Mounjaro (including what a complete service actually covers) that page gives an honest account of what you're paying for. The clinical team at nume reviews every consultation personally; if post-meal fatigue is affecting your daily life, it's exactly the kind of thing worth raising when you speak to our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.